India's First Indigenously Developed Antibiotic, Nafithromycin, Aims to Combat Antimicrobial Resistance
Journal of Innovations in Pharmaceutical and Biological Sciences · 2026 · 13 (01) · 01-02
DOI: 10.56511/jipbs.2026.13101 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Innovations in Pharmaceutical and Biological Sciences, 2026. Verfasst von Ansari Vikhar Danish Ahmad und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ahmad, A. V. D., Shaikh, M. S., & Khan, S. (2026). India's First Indigenously Developed Antibiotic, Nafithromycin, Aims to Combat Antimicrobial Resistance. Journal of Innovations in Pharmaceutical and Biological Sciences, 13(01), 01-02. https://doi.org/10.56511/jipbs.2026.13101
Vancouver
Ahmad AVD, Shaikh MS, Khan S. India's First Indigenously Developed Antibiotic, Nafithromycin, Aims to Combat Antimicrobial Resistance. Journal of Innovations in Pharmaceutical and Biological Sciences. 2026;13(01):01-02. doi:10.56511/jipbs.2026.13101
BibTeX
@article{Ahmad2026,
author = {Ahmad, Ansari Vikhar Danish and Shaikh, Mohd Sayeed and Khan, Sarfaraz},
title = {India's First Indigenously Developed Antibiotic, Nafithromycin, Aims to Combat Antimicrobial Resistance},
journal = {Journal of Innovations in Pharmaceutical and Biological Sciences},
year = {2026},
volume = {13},
number = {01},
pages = {01--02},
doi = {10.56511/jipbs.2026.13101}
}
EUVIMED